[go: up one dir, main page]

AU2001271426A1 - Modulation of apoptosis - Google Patents

Modulation of apoptosis

Info

Publication number
AU2001271426A1
AU2001271426A1 AU2001271426A AU7142601A AU2001271426A1 AU 2001271426 A1 AU2001271426 A1 AU 2001271426A1 AU 2001271426 A AU2001271426 A AU 2001271426A AU 7142601 A AU7142601 A AU 7142601A AU 2001271426 A1 AU2001271426 A1 AU 2001271426A1
Authority
AU
Australia
Prior art keywords
apoptosis
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271426A
Inventor
Stanley J Korsmeyer
Paul H Schlesinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU2001271426A1 publication Critical patent/AU2001271426A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1761—Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001271426A 2000-07-17 2001-06-25 Modulation of apoptosis Abandoned AU2001271426A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61787800A 2000-07-17 2000-07-17
US09/617,878 2000-07-17
PCT/US2001/020169 WO2002005835A2 (en) 2000-07-17 2001-06-25 Modulation of apoptosis

Publications (1)

Publication Number Publication Date
AU2001271426A1 true AU2001271426A1 (en) 2002-01-30

Family

ID=24475412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271426A Abandoned AU2001271426A1 (en) 2000-07-17 2001-06-25 Modulation of apoptosis

Country Status (2)

Country Link
AU (1) AU2001271426A1 (en)
WO (1) WO2002005835A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2401272B (en) 2003-04-30 2007-11-21 Hewlett Packard Development Co Method and apparatus for enhancing user interest in static digital images
DE10337905A1 (en) * 2003-08-18 2005-03-24 Universität Duisburg-Essen Using apoptosis-regulating agent for treating disease, e.g. neurodegeneration or autoimmune diseases, acts by modifying interaction of mitochondrial potassium channels with apoptosis inducers
CA2546794C (en) 2003-11-19 2013-09-17 Survac Aps Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
FR2881430B1 (en) * 2005-02-01 2010-10-22 Servier Lab NOVEL PEPTIDES INTERACTING WITH ANTI-APOPTOTIC MEMBERS OF THE BCL-2 PROTEIN FAMILY AND USES THEREOF
FR2949787A1 (en) * 2009-09-09 2011-03-11 Centre Nat Rech Scient MOLECULES CAPABLE OF PERFORATING MITOCHONDRIA AND THEIR APPLICATIONS
EP2863920B1 (en) 2012-06-20 2023-03-22 Eutropics Pharmaceuticals, Inc. Quinoline derivatives for use in the tratment of breast cancer
EP2922544B1 (en) 2012-11-21 2018-08-01 Eutropics Pharmaceuticals, Inc. Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
US10732182B2 (en) 2013-08-01 2020-08-04 Eutropics Pharmaceuticals, Inc. Method for predicting cancer sensitivity
WO2015066305A1 (en) 2013-10-30 2015-05-07 Eutropics Pharmaceuticals, Inc. Methods for determining chemosensitivity and chemotoxicity
US10793915B2 (en) 2015-01-12 2020-10-06 Eutropics Pharmaceuticals, Inc. Context dependent diagnostics test for guiding cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165732A (en) * 1997-10-14 2000-12-26 Washington University Method for identifying apoptosis modulating compounds

Also Published As

Publication number Publication date
WO2002005835A3 (en) 2003-01-03
WO2002005835A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2002213467A1 (en) Modulation of ccr4 function
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2001239971A1 (en) Antisense modulation of parp expression
AU2002306918A1 (en) Methods of modulating angiogenesis
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2002320525A1 (en) Antisense modulation of glioma-associated oncogene-2 expression
AU2001230605A1 (en) Apoptosis inhibitor
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2001271426A1 (en) Modulation of apoptosis
AU2002318139A1 (en) Antisense modulation of src-c expression
AU2002230869A1 (en) Antisense modulation of hepsin expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU2001280588A1 (en) Methods of modulating angiogenesis
EP1368891B8 (en) Iq modulator
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2003295790A1 (en) Modulation of iap-like expression
AU2001275063A1 (en) Regulators of apoptosis
AU2002328209A1 (en) Hierarchical modulation
AU2002307413A1 (en) Modulators of angiogenesis
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression
AU2001256507A1 (en) Modulation
AU2000268585A1 (en) Phase modulator
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU3679800A (en) Apoptosis inhibitors